Skip to content

Effect of early tirofiban adminstration in emergency department on TIMI flow 3

Study of the effect of early bolus dose of tirofiban in emergency department on early TIMI flow 3 of the patients with myocardial infarction undergoing primary PCI

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT201105126463N1
Enrollment
140
Registered
2011-06-06
Start date
2011-03-06
Completion date
Unknown
Last updated
2018-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute myocardial infarction. Acute myocardial infarction

Interventions

Intervention 1: Intervention group are prescribed 25 mcg/kg of bolus intravenous tirofiban in 1-3 minutes as soon as possible in the emergency department. Intervention 2: The control group will not r

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 75 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Acute myocardial infarction patient with ST segment elevation or new left bundle branch block in 12 hours of onset of symptoms and are candidate for primary PCI within 90 minutes of presentations to the emergency department

Exclusion criteria

Exclusion criteria: Exclusion criteria: Stroke or TIA within the past 30 days or any history of hemorrhagic stroke, well known intra cranial disease (neoplasm or aneurysm), any active bleeding or bleeding history in past 30 days, uncontrolled HTN at registry time (SBP>180, DBP>110), Major operation or trauma in recent 6 weeks, platlete count less than 100000 or bleeding conditions, Coagulation disorders (INR>1.5), Severe hepatic failure, Administration of any fibrinolytic treatment 24 hours from randomization, Renal failure (Cr>205mg/dl or GFR <30), age more than 75 years old

Design outcomes

Primary

MeasureTime frame
Prevalence of TIMI 3 flow score in coronary angiography. Timepoint: in cath lab before PCI. Method of measurement: according to angiography report.

Secondary

MeasureTime frame
Major Cardiac Event. Timepoint: one year. Method of measurement: clinical follow up.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Seyed Hesameddin Abbasi

Tehran Heart Center

Abbasi.hesam@gmail.com+98 21 8802 9702

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Mar 21, 2026